TNFRSF12A and neoplasm: According to new research, an antibody against fibroblast growth factor-inducible 14 (Fn14), a receptor for the TWEAK cytokine, increased lifespan in C26 tumor-bearing mice by preventing tumor-induced weight loss, which could be a promising treatment option for cachectic patients [117].